Literature DB >> 1511463

Effect of picibanil (OK432) on neutrophil-mediated antitumor activity: implication of monocyte-derived neutrophil-activating factors.

K D Yang1, R M Stone, C S Lee, T Y Chao, S N Cheng, M F Shaio.   

Abstract

Picibanil (OK432), an extract from streptococci, has been widely utilized to treat malignant ascites and pleural effusions. The antitumor mechanism is believed to include complement-mediated neutrophil activation. Employing a flow-cytometric analysis of actin polymerization as an indicator of cell activation as well as a tumor proliferation assay, we have found that monocyte-derived neutrophil-activating factors were involved in OK432-induced neutrophil activation as well as antitumor activity. OK432-stimulated (0.1 KE/ml; 0.01 mg/ml) monocyte supernatants (OKMS) induced neutrophil actin polymerization and chemotaxis. OKMS were responsible for neutrophil-mediated inhibition of human leukemic (CEM) cell proliferation and stimulated neutrophils to produce superoxide in the presence of CEM leukemic cells at an effector/target ratio higher than 20/1. In contrast, OK432 alone, OK432-stimulated lymphocyte supernatants, or OK432-stimulated neutrophil supernatants had no effect on neutrophil activation or suppression of tumor cell proliferation. OK432 in combination with mononuclear cells also had no effect on the inhibition of CEM cell proliferation. Pretreatment of OKMS at 56 degrees C for 30 min did not affect its ability to activate neutrophils, implying that complement activation is not responsible for the neutrophil activation. Supernatants from OK432-stimulated mononuclear cells, as determined by enzyme-linked immunosorbent assays and radioimmunoassays, contained high levels of interleukin-8 (IL-8; 1567 +/- 145 pg/ml) and tumor necrosis factor (TNF alpha; 2105 +/- 152 pg/ml), low levels of leukotriene B4 (800 +/- 45 pg/ml) and IL-1 beta (180 +/- 22 pg/ml), but interferon gamma was not detectable. IL-1 beta, IL-8, and TNF alpha transcripts, undetectable in untreated monocytes, increased significantly after 30-60 min exposure to OK432. These results suggest that neutrophil-activating factors from monocytes or resident macrophages may play an important role in the OK432-induced neutrophil activation and antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1511463     DOI: 10.1007/bf01789335

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  31 in total

1.  The actin content of fibroblasts.

Authors:  D Bray; C Thomas
Journal:  Biochem J       Date:  1975-05       Impact factor: 3.857

2.  Studies on the mechanism of antibody-dependent polymorphonuclear leukocyte-mediated cytotoxicity.

Authors:  R A Clark; S J Klebanoff
Journal:  J Immunol       Date:  1977-10       Impact factor: 5.422

3.  Neutrophil migration induced by inflammatory stimuli is reduced by macrophage depletion.

Authors:  G E Souza; F Q Cunha; R Mello; S H Ferreira
Journal:  Agents Actions       Date:  1988-07

4.  Treatment of malignant ascites and pleurisy by a streptococcal preparation OK-432 with fresh frozen plasma--a mechanism of polymorphonuclear leukocyte (PMN) accumulation.

Authors:  H Kato; Y Yamamura; R Kin; M Tanigawa; H Sano; M Inoue; S Sugino; M Kondo
Journal:  Int J Immunopharmacol       Date:  1989

5.  Human alveolar macrophage gene expression of interleukin-8 by tumor necrosis factor-alpha, lipopolysaccharide, and interleukin-1 beta.

Authors:  R M Strieter; S W Chensue; M A Basha; T J Standiford; J P Lynch; M Baggiolini; S L Kunkel
Journal:  Am J Respir Cell Mol Biol       Date:  1990-04       Impact factor: 6.914

6.  Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites.

Authors:  R M Stone; K Imamura; R Datta; M L Sherman; D W Kufe
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

7.  Mechanism of polymorphonuclear leukocytes accumulation examined using inhibitors of complement and arachidonic acid cascade in rats treated with OK-432.

Authors:  H Kato; M Inoue; Y Yamamura; M Tanigawa; H Sano; S Sugino; M Kondo
Journal:  Nat Immun Cell Growth Regul       Date:  1989

8.  Human neutrophil-mediated cytotoxicity to tumor cells.

Authors:  T L Gerrard; D J Cohen; A M Kaplan
Journal:  J Natl Cancer Inst       Date:  1981-03       Impact factor: 13.506

9.  Chemotactic peptide modulation of actin assembly and locomotion in neutrophils.

Authors:  T H Howard; W H Meyer
Journal:  J Cell Biol       Date:  1984-04       Impact factor: 10.539

10.  Chemotactic peptide-induced changes in neutrophil actin conformation.

Authors:  P J Wallace; R P Wersto; C H Packman; M A Lichtman
Journal:  J Cell Biol       Date:  1984-09       Impact factor: 10.539

View more
  3 in total

1.  OK-432 sclerotherapy of lymphatic malformation in the head and neck: factors related to outcome.

Authors:  Dong Wook Kim
Journal:  Pediatr Radiol       Date:  2014-02-26

2.  The preventive effects of OK432 on endotoxin-induced liver injury: liver protection by the modulation of hepatic macrophage function.

Authors:  S Fujita; S Arii; K Monden; S Ishiguro; T Nakamura; M Mizumoto; M Imamura
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

3.  The prognostic advantage of preoperative intratumoral injection of OK-432 for gastric cancer patients.

Authors:  A Gochi; K Orita; S Fuchimoto; N Tanaka; N Ogawa
Journal:  Br J Cancer       Date:  2001-02       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.